Clinical Trials
Company-Supported Clinical Trials
Key clinical trials sponsored by Mallinckrodt for branded drugs are listed on www.clinicaltrials.gov and detailed below, with a link provided to learn more and an indicator of the current phase of development.
| Study Title | PHASE 1 | PHASE 2 | PHASE 3 | PHASE 4 |
|---|---|---|---|---|
| A Multicenter, 2-Part Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Rheumatoid Arthritis More Information > |
X | |||
| A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin (CONFIRM) More Information > |
X | |||
| A Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Active Systemic Lupus Erythematosus (SLE) More Information > |
X | |||
| A Study to Assess the Efficacy and Safety of MNK-1411 in Duchenne Muscular Dystrophy (BRAVE) More Information > | X | |||
| ACTH as a Re-emerging Therapy for Uveitis (The ACTHAR Study) More Information > | X | |||
| Acthar for the Treatment of Systemic Lupus Erythematosus in Patients With a History of Persistently Active Disease More Information > |
X | |||
| ExpressGraft-C9T1 Skin Tissue as a Treatment of Diabetic Foot Ulcers More Information > |
X | |||
| Follow up Study of Patients Having Participated in Clinical Trial 64,185-204 (JASMINE_205) More Information > |
||||
| MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy) More Information > |
X | |||
| Observational Registry Of H.P. Acthar® Gel for Multiple Sclerosis Relapse More Information > |
X | |||
| Pilot Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Pulmonary Sarcoidosis More Information > |
X | |||
| Pilot Study to Assess the Efficacy and Safety of H.P. Acthar® Gel in Subjects With Relapsing-Remitting Multiple Sclerosis (OPTIONS) More Information > |
X | |||
| Registry Evaluating Premature and Term-Near-Term Neonates With Pulmonary Hypertension Receiving Inhaled Nitric Oxide (PaTTerN) More Information > |
X | |||
| StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements More Information > |
X | |||
| StrataGraft® Skin Tissue as an Alternative to Autografting Full-thickness Complex Skin Defects More Information > |
X | |||
| Treatment of Proteinuria Due to Treatment Resistant or Treatment Intolerant Idiopathic FSGS (PODOCYTE) More Information > |
X |